insights_auto
Outlook: 50.0% bullish·16.7% bearish
Go to analysischevron_right
GMED:NYSE
Globus Medical Inc
$79.32
arrow_upward
+0.61%(+0.48) 1D
Oct 15, 4:00:08 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMED...
Mkt. cap
10.59B
Avg. vol.
1.58M
Volume
1.11K
P/E ratio
20.16
52-wk high
$101.40
52-wk low
$58.51
EPS
$3.91
Beta
0.96
Shares outstanding
112.62M
No. of employees
6K
Mkt. cap
10.59B
Avg. vol.
1.58M
Volume
1.11K
P/E ratio
20.16
52-wk high
$101.40
52-wk low
$58.51
EPS
$3.91
Beta
0.96
Shares outstanding
112.62M
No. of employees
6K
News stories
From web sources and news partners
Zacks
·
1 hour ago
Reasons to Add STE Stock to Your Portfolio Right Now
Zacks
·
1 hour ago
Haemonetics Gains 149.3% in a Year: What's Driving the Rally?
Zacks
·
1 hour ago
Is it Apt to Retain Medtronic Stock in Your Portfolio Now?
Zacks
·
20 hours ago
BD's Revello Stent Shows Strong AGILITY Trial Results for PAD Patients
Profile
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders. Wikipedia
About Globus Medical Inc